IN
Amplia Therapeutics Limited
INNMF · OTC
$0.08 +6.31% (+$0.00)
1M -20.52%
Market Cap $60.2M
P/E Ratio -
Div. Yield -
ROE 22.61%
Piotroski F-Score Weak
1/9Valuation
35 /100
Fair P/B 2.86x
P/S 15.90x
EV/EBITDA N/A
Growth
82 /100
Growing Book val. growth 1.27%
Rev. growth 24.02%
FCF growth N/A
Profitability
20 /100
Weak Net margin 173.69%
Op. margin 172.22%
FCF margin 182.04%
Quality
2 /100
Poor ROE 22.61%
ROA 28.65%
Asset turnover 0.16x
Debt
100 /100
Low Current ratio 7.91x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
34 /100
Moderate Rev. volatility 174.73%
EPS volatility 28.77%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about INNMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Burns
Employees
1
Headquarters
Melbourne
Upcoming events
27 NOV
Earnings
Upcoming earnings report